Alerts will be sent to your verified email
Verify Email
AARTIDRUGS
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Aarti Drugs Limited, a key player in the pharmaceutical industry, specializes in manufacturing APIs, Pharma Intermediates, Specialty Chemicals, and Formulations including Ciprofloxacin Hydrochloride and Metronidazole.
Aarti Drugs major competitors are Supriya Lifescience, Solara Active Pharma, IOL Chem & Pharma, Morepen Laboratories, SMS Pharmaceuticals, Hester Biosciences, Bajaj Healthcare.
Market Cap of Aarti Drugs is ₹4,319 Crs.
While the median market cap of its peers are ₹2,639 Crs.
Aarti Drugs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Jul | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Mar Jun Sep Dec | Mar Jun Sep | ||||||||
| Investor Presentation | May Jul | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar May Jun Jul Aug Sep Dec | Jan Mar Jun Sep Dec | Mar Jun Sep Dec | Mar | Jun Sep Dec | ||||||||||
| Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep | |||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
